Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Excisional biopsy, auxillary node dissection and definitive radiotherapy for Stages I and II breast cancer

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
From 1977 to 1982, 189 patients with clinical Stage I and II breast cancer underwent excisional biopsy and auxillary node dissection followed by definitive radiotherapy at the University of Pennsylvania. One hundred and nine patients had T/sub 1/ lesions and 80 had T/sub 2/ lesions. Histologically negative nodes were found in 136 patients (72%) and histologically positive nodes in 53 patients. Median follow-up from the completion of radiotherapy was 26 months. The four year actuarial disease free survival is 82% for pathologic Stage I and 70% for pathologic Stage II. Cosmesis was judged to be good to excellent in 90% and fair in 9%. Complications included arm edema (7%), symptomatic pneumonitis (1%), rib fractures (1%), pericarditis (1%) and pleural effusion (1%). Primary radiotherapy for Stages I and II breast cancer produces a local-regional control rate of 95% and good to excellent cosmesis in 90% of the patients. While these results are preliminary, they compare favorably with other reported series.
Research Organization:
Univ. of Pennsylvania School of Medicine, Philadelphia
OSTI ID:
5674325
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 11:3; ISSN IOBPD
Country of Publication:
United States
Language:
English

Similar Records

Analysis of cosmetic results and complications in patients with Stage I and II breast cancer treated by biopsy and irradiation
Journal Article · Wed Nov 30 23:00:00 EST 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5010500

Analysis of cosmetic results and complications in patients with Stage I and II breast cancer treated by biopsy and irradiation
Journal Article · Wed Nov 30 23:00:00 EST 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5126366

A Phase II Study of Radiotherapy and Concurrent Paclitaxel Chemotherapy in Breast-Conserving Treatment for Node-Positive Breast Cancer
Journal Article · Sat Dec 31 23:00:00 EST 2011 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22055908